在线学术报告 ｜ 杨淑副教授：利用RWD的综合信息进行RCT分析

　　原标题：在线学术报告 | 杨淑副教授：利用RWD的综合信息进行RCT分析

　　

　　摘要

　　Parallel randomized clinical trial (RCT) and real-world data (RWD) are becoming increasingly available for treatment evaluation. Given the complementary features of the RCT and RWD, I first discuss the common questions that can be answered by integrative analysis of RCT and RWD (Yang and Wang, 2022; Colnet et al, 2022). Then, I will present a test-based elastic integrative analysis of RCT and RWD for accurate and robust estimation of the heterogeneity of treatment effect (HTE), which lies at the heart of precision medicine. When the RWD are not subject to bias, e.g., due to hidden confounding, our approach combines the RCT and RWD for optimal estimation by exploiting semiparametric efficiency theory. Utilizing the design advantage of RCTs, we construct a built-in test procedure to gauge the reliability of the RWD and decide whether or not to use RWD in an integrative analysis. A data-adaptive procedure is proposed to select the threshold of the test statistic that promises the smallest mean square error of the proposed estimator of the HTE. Lastly, we construct an adaptive confidence interval that has a good finite-sample coverage property. We apply the proposed method to characterize who can benefit from adjuvant chemotherapy in patients with stage IB non-small cell lung cancer.

　　Paper #1: S. Yang and X. Wang (2022). RWD-integrated randomized clinical trial analysis. 2022 ASA Biopharmaceutical Report Real World Evidence (Editors: Herbert Pang, Ling Wang, Kristi L. Griffiths), 29, 15–21.

　　Paper #2: B. Colnet, I. Mayer, G. Chen, A. Dieng, R. Li, G. Varoquaux, J.P. Vert, J. Josse, S. Yang (2022). Causal inference methods for combining randomized trials and observational studies: a review. Statistical Science, accepted.

　　https://arxiv.org/abs/2011.08047

　　Paper #3: S. Yang, C. Gao, X. Wang, and D. Zeng (2022). Elastic integrative analysis of randomized trial and real-world data for treatment heterogeneity estimation. Journal of the Royal Statistical Society: Series B, accepted.

　　嘉宾介绍

　　Shu Yang （杨淑）is Associate Professor of Statistics, Goodnight Early Career Innovator, and University Faculty Scholar at North Carolina State University. She received her Ph.D. in Applied Mathematics and Statistics from Iowa State University and postdoctoral training at Harvard T.H. Chan School of Public Health. Her primary research interest is causal inference and data integration, particularly with applications to comparative effectiveness research in health studies. She also works extensively on methods for missing data and spatial statistics. She has been co-Investigator for a Patient-Centered Outcomes Research Institute grant and Principal Investigator for U.S. National Science Foundation and National Institute of Health research projects.

　　狗熊会线上学术报告厅向数据科学及相关领域的学者及从业者开放，非常期待各位熊粉报名或推荐报告人。相关事宜，请联系：常莹，ying.chang@clubear.org。

　　请添加熊二(clubear2)获取参会方式~

　　责任编辑：